Cargando…
Correspondence to: “A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients.”
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559198/ https://www.ncbi.nlm.nih.gov/pubmed/34729156 http://dx.doi.org/10.1177/20406223211050495 |
_version_ | 1784592710843236352 |
---|---|
author | Bansal, Pankaj Sanghavi, Devang |
author_facet | Bansal, Pankaj Sanghavi, Devang |
author_sort | Bansal, Pankaj |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8559198 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-85591982021-11-01 Correspondence to: “A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients.” Bansal, Pankaj Sanghavi, Devang Ther Adv Chronic Dis Letter to the Editor SAGE Publications 2021-10-28 /pmc/articles/PMC8559198/ /pubmed/34729156 http://dx.doi.org/10.1177/20406223211050495 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Letter to the Editor Bansal, Pankaj Sanghavi, Devang Correspondence to: “A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients.” |
title | Correspondence to: “A meta-analysis of granulocyte-macrophage
colony-stimulating factor (GM-CSF) antibody treatment for COVID-19
patients.” |
title_full | Correspondence to: “A meta-analysis of granulocyte-macrophage
colony-stimulating factor (GM-CSF) antibody treatment for COVID-19
patients.” |
title_fullStr | Correspondence to: “A meta-analysis of granulocyte-macrophage
colony-stimulating factor (GM-CSF) antibody treatment for COVID-19
patients.” |
title_full_unstemmed | Correspondence to: “A meta-analysis of granulocyte-macrophage
colony-stimulating factor (GM-CSF) antibody treatment for COVID-19
patients.” |
title_short | Correspondence to: “A meta-analysis of granulocyte-macrophage
colony-stimulating factor (GM-CSF) antibody treatment for COVID-19
patients.” |
title_sort | correspondence to: “a meta-analysis of granulocyte-macrophage
colony-stimulating factor (gm-csf) antibody treatment for covid-19
patients.” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559198/ https://www.ncbi.nlm.nih.gov/pubmed/34729156 http://dx.doi.org/10.1177/20406223211050495 |
work_keys_str_mv | AT bansalpankaj correspondencetoametaanalysisofgranulocytemacrophagecolonystimulatingfactorgmcsfantibodytreatmentforcovid19patients AT sanghavidevang correspondencetoametaanalysisofgranulocytemacrophagecolonystimulatingfactorgmcsfantibodytreatmentforcovid19patients |